Roger E. Susi - Feb 17, 2022 Form 4 Insider Report for IRADIMED CORP (IRMD)

Role
President, CEO and Chairman, Director, 10%+ Owner
Signature
/s/ Roger E. Susi
Stock symbol
IRMD
Transactions as of
Feb 17, 2022
Transactions value $
-$471,506
Form type
4
Date filed
2/22/2022, 03:10 PM
Previous filing
Feb 8, 2022
Next filing
Feb 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRMD Common Stock Sale -$472K -10K -1.35% $47.15 733K Feb 17, 2022 By Roger E. Susi Revocable Trust F1, F2
holding IRMD Common Stock 2.36M Feb 17, 2022 By Matthew Susi 2008 Dynasty Trust F3
holding IRMD Common Stock 2.36M Feb 17, 2022 By Phillip Susi 2008 Dynasty Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Roger E. Susi is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $46.13 to $48.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.